Product
NNC0365-3769 (Mim8)
1 clinical trial
2 indications
Indication
Hemophilia AIndication
Hemophilia A with InhibitorsClinical trial
Open-label Safety Study in Adults and Adolescents With Haemophilia A With and Without FVIII Inhibitors Switching Directly From Emicizumab Prophylaxis to NNC0365-3769 (Mim8) ProphylaxisStatus: Active (not recruiting), Estimated PCD: 2024-09-09